Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Results should be interpreted with a qualified healthcare provider as one data point among many
Thus, it is feasible that even if there may be a tumor-promoting effect that the duration of drug exposure may not be sufficient to significantly increase the risk of tumorigenesis
Contact: Rebecca Alder +44 1983 866780 [email protected] 1 Ziemke F
[18] [19] The SURMOUNT-1 trial, which assessed tirzepatide for weight management, showed higher rates, with nausea affecting approximately 31% of participants at the 15 mg dose
US$ 24.22
US$ 24.77
US$ 29.21
